# US 2010/0167289 A1 · Multi-color time resolved fluorophores based on macrocyclic lanthanide complexes

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2010/0167289 A1
- Document ID: US20100167289A1
- Status: Published application
- Kind: A1
- Application number: 12/521,910
- Filed: 2008-01-25
- Published: 2010-07-01
- Earliest claimed: 2007-01-25
- Assignees: Lumiphore, Inc.
- Inventors: Nathaniel G. Butlin; Todd M. Corneillie; Jide Xu
- Web page: https://patentgrep.com/patent/US20100167289A1

## CPC

- C07D 487/18: Bridged systems
- A61K 49/0043: {Fluorescein, used in vivo}
- A61K 49/0052: {Small organic molecules (oligomers, polymers, dendrimers A61K49/0054)}
- C09B 11/24: Phthaleins containing amino groups {; Phthalanes; Fluoranes; Phthalides; Rhodamine dyes; Phthaleins having heterocyclic aryl rings; Lactone or lactame forms of triarylmethane dyes}
- C09B 57/10: Metal complexes of organic compounds not being dyes in uncomplexed form
- C09K 11/06: containing organic luminescent materials
- G01N 33/533: with fluorescent label
- C09K 2211/145: containing oxygen as the only heteroatom
- C09K 2211/1466: containing nitrogen as the only heteroatom
- C09K 2211/182: of the rare earth metals, i.e. Sc, Y or lanthanide
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- C09B: ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES {, e.g. PIGMENTS}; MORDANTS; LAKES (fermentation or enzyme using processes to synthesise a desired chemical compound C12P)
- C09K: MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

The present invention provides a novel class of macrocyclic compounds as well as complexes formed between a metal (e.g., lanthanide) ion and the compounds of the invention. Preferred complexes exhibit high stability as well as high quantum yields of lanthanide ion luminescence in aqueous media without the need for secondary activating agents. Preferred compounds incorporate hydroxy-isophthalamide moieties within their macrocyclic structure and are characterized by surprisingly low, non-specific binding to a variety of polypeptides such as antibodies and proteins as well as high kinetic stability. These characteristics distinguish them from known, open-structured ligands.

## Claims

### Claim 1

A compound having a structure according to Formula I:
wherein
each Z is a member independently selected from O and S;
L1, L2, L3, L4, L5, L6, L7, L8, L9 and L10 are linker groups independently selected from substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, substituted or unsubstituted heterocycloalkyl and nucleic acid;
A1, A2, A3 and A4 are members independently selected from the general structure:
wherein
each R1 is a member independently selected from H, an enzymatically labile group, a hydrolytically labile group, a metabolically labile group and a single negative charge; and
each R5, R6 and R7 is a member independently selected from H, substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, halogen, CN, CF3, acyl, —SO2NR17R18, —NR17R18, —OR17, —S(O)2R17, —COOR17, —S(O)2OR17, —OC(O)R17, —C(O)NR17R18, —NR17C(O)R18, —NR17SO2R18, and NO2,
wherein
R6 and a member selected from R5, R7 and combinations thereof are optionally joined to form a ring system which is a member selected from substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl and substituted or unsubstituted heteroaryl,
R17 and R18 are members independently selected from H, substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl and substituted or unsubstituted heterocycloalkyl, and R17 and R18, together with the atoms to which they are attached, are optionally joined to form a 5- to 7-membered ring, and
(a) a first moiety selected from L1, L2, L3, L4, L5, L6, L7, L8, L9, L10, R1, R5, R6 and R7 comprises a acceptor-linker covalently attached to a fluorophore
wherein said acceptor-linker and said fluorophore are covalently joined through a linkage fragment; or
(b) a first moiety selected from L1, L2, L3, L4, L5, L6, L7, L8, L9, L10, R1, R5, R6 and R7 comprises a acceptor-linker and a second moiety selected from L1, L2, L3, L4, L5, L6, L7, L8, L9, L10, R1, R5, R6 and R7 comprises a functional moiety, wherein said first moiety and said second moiety are different moieties; or
(c) a first moiety selected from L1, L2, L3, L4, L5, L6, L7, L8, L9, L10, R1, R5, R6 and R7 comprises a acceptor-linker covalently joined, through a linkage fragment, to a fluorophore; and
a second moiety selected from L1, L2, L3, L4, L5, L6, L7, L8, L9, L10, R1, R5, R6 and R7 comprises a functional moiety
wherein said first moiety and said second moiety, each selected from L1, L2, L3, L4, L5, L6, L7, L8, L9, L10, R1, R5, R6 and R7, are different moieties; or
(d) a first moiety selected from L1, L2, L3, L4, L5, L6, L7, L8, L9, L10, R1, R5, R6 and R7 comprises a acceptor-linker; and
a second moiety selected from L1, L2, L3, L4, L5, L6, L7, L8, L9, L10, R1, R5, R6 and R7 comprises a functional moiety covalently joined, through a linkage fragment, to a member selected from a carrier moiety and a solid support
wherein said first moiety and said second moiety, each selected from L1, L2, L3, L4, L5, L6, L7, L8, L9, L10, R1, R5, R6 and R7, are different moieties; or
(e) a first moiety selected from L1, L2, L3, L4, L5, L6, L7, L8, L9, L10, R1, R5, R6 and R7 comprises a acceptor-linker covalently joined, through a linkage fragment, to a fluorophore; and
a second moiety selected from L1, L2, L3, L4, L5, L6, L7, L8, L9, L10, R1, R5, R6 and R7 comprises a functional moiety covalently joined, through a linkage fragment, to a member selected from a carrier moiety and a solid support
wherein said first moiety and said second moiety, each selected from L1, L2, L3, L4, L5, L6, L7, L8, L9, L10, R1, R5, R6 and R7, are different moieties
(f) a first moiety selected from L1, L2, L3, L4, L5, L6, L7, L8, L9, L10, R1, R5, R6 and R7 comprises a moiety which is both a fluorescent-linker and a functional moiety; or
(g) a first moiety selected from L1, L2, L3, L4, L5, L6, L7, L8, L9, L10, R1, R5, R6 and R7 comprises a moiety which is both a fluorescent-linker and a functional moiety covalently bound, through at least one linkage fragment to at least one member selected from a fluorophore, a carrier moiety, a solid support and a combination thereof, wherein each of said at least one linkage fragment is the same or different.

### Claim 2 (depends on 1)

The compound according to claim 1, having the structure:

### Claim 3 (depends on 1)

The compound according to claim 1, having a structure, which is a member selected from:
wherein
L11 is a member selected from a bond, acyl, substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, substituted or unsubstituted heterocycloalkyl and nucleic acid; and
X is a linkage fragment covalently binding a fluorophore to L11.

### Claim 4 (depends on 1)

The compound according to claim 1, wherein said linker moieties L1, L2, L3, L4, L5, L6, L7, L8, L9 and L10 are members independently selected from substituted or unsubstituted C1 to C6 alkyl.

### Claim 5 (depends on 4)

The compound according to claim 4, wherein said linker moieties L1, L2, L3, L4, L5, L6, L7, L8, L9 and L10 are members independently selected from substituted or unsubstituted ethyl.

### Claim 6 (depends on 1)

A luminescent complex formed between at least one metal ion and a compound according to claim 1.

### Claim 7 (depends on 6)

The complex according to claim 6, wherein said metal ion is a lanthanide ion.

### Claim 8 (depends on 7)

The complex according to claim 7, wherein said lanthanide is a member selected from neodynium (Nd), samarium (Sm), europium (Eu), terbium (Tb), dysprosium (Dy) and ytterbium (Yb).

### Claim 9 (depends on 6)

A method of detecting an analyte in a sample, said method comprising:
(a) contacting said analyte with a compound according to claim 6, wherein an energy transfer pair is formed between said compound and a member selected from said analyte, a fluorophore bound to said analyte and a combination thereof;
(b) exciting said compound such that said compound transfers excitation energy to a member selected from said analyte, said fluorophore bound to said analyte; and
(c) detecting energy emitted by a member selected from said analyte, said fluorophore bound to said analyte and a combination thereof, thereby detecting said analyte.

### Claim 10 (depends on 9)

The method according to claim 9 wherein said analyte is a nucleic acid.

### Claim 11 (depends on 9)

The method of claim 9 wherein the method is performed in vivo.

### Claim 12 (depends on 9)

The method of claim 9 wherein the sample contains a living cell.

### Claim 13 (depends on 10)

The method of claim 10 wherein said nucleic acid comprises a genetic point mutation, deletion or insertion relative to a control nucleic acid.

### Claim 14 (depends on 10)

The method of claim 10 wherein the detection of said nucleic acid indicates the presence of a cancer in the sample.

### Claim 15 (depends on 10)

The method of claim 10 wherein the detection of said nucleic acid indicates an alteration of the expression pattern of said nucleic acid in response to an external stimulus.

### Claim 16 (depends on 9)

The method of claim 9 wherein the detecting is performed with single- or multiple-photon microscopy, time-resolved fluorescence microscopy or fluorescence endoscopy.

### Claim 17

A mixture comprising:
(i) a first compound having a structure according to Formula I:
wherein
each Z is a member independently selected from O and S;
L1, L2, L3, L4, L5, L6, L7, L8, L9 and L10 are linker groups independently selected from substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl and substituted or unsubstituted heterocycloalkyl;
A1, A2, A3 and A4 are members independently selected from the general structure:
wherein
each R1 is a member independently selected from H, an enzymatically labile group, a hydrolytically labile group, a metabolically labile group and a single negative charge; and
each R5, R6 and R7 is a member independently selected from H, substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, halogen, CN, CF3, acyl, —SO2NR17R18, —NR17R18, —OR17, —S(O)2R17, —COOR17, —S(O)2OR17, —OC(O)R17, —C(O)NR17R18, —NR17C(O)R18, —NR17SO2R18, and —NO2,
wherein
R6 and a member selected from R5, R7 and combinations thereof are optionally joined to form a ring system which is a member selected from substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl and substituted or unsubstituted heteroaryl,
R17 and R18 are members independently selected from H, substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl and substituted or unsubstituted heterocycloalkyl, and R17 and R18, together with the atoms to which they are attached, are optionally joined to form a 5- to 7-membered ring; and
(ii) a second compound having a member selected from a fluorophore and a quencher attached thereto.

### Claim 18 (depends on 17)

The mixture according to claim 17 wherein said first compound is a luminescent metal ion complex, and said first compound and said second compound interact such that an energy exchange pair is formed wherein excitation energy from said first compound is transferred to a member selected from said fluorophore of said second compound and said quencher of said second compound.

### Claim 19 (depends on 18)

The mixture according to claim 18, wherein metal ion is a lanthanide ion which is a member selected from neodynium (Nd), samarium (Sm), europium (Eu), terbium (Tb), dysprosium (Dy) and ytterbium (Yb).

### Claim 20 (depends on 19)

The mixture according to claim 19 wherein said first compound is covalently attached through a functional moiety to a first nucleic acid.

### Claim 21 (depends on 20)

The mixture according to claim 20 wherein said second compound is a nucleic acid.

### Claim 22 (depends on 21)

The mixture according to claim 21 wherein said first nucleic acid and said second nucleic acid independently comprise from about 5 to about 50 nucleotides.

### Claim 23 (depends on 22)

The mixture according to claim 22 wherein said first nucleic acid and said second nucleic acid independently comprise from 10 to 40 nucleotides.

### Claim 24 (depends on 23)

The mixture according to claim 23, wherein said first nucleic acid and said second nucleic acid independently comprise from 15 to 30 nucleotides.

### Claim 25

The mixture according to 21 wherein one member selected from said first nucleic acid, said second nucleic acid and a combination thereof participates in both stem-loop formation and hybridization to the target sequence nucleic acid.
